z-logo
Premium
Novel and recurrent mutations in the filaggrin gene in Chinese patients with ichthyosis vulgaris
Author(s) -
Zhang X.,
Liu S.,
Chen X.,
Zhou B.,
Liu D.,
Lei G.,
Xiao X.,
Liu H.,
Wang H.
Publication year - 2010
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/j.1365-2133.2010.09740.x
Subject(s) - ichthyosis vulgaris , china , zhàng , library science , medicine , filaggrin , history , dermatology , computer science , atopic dermatitis , archaeology
Summary Background  Ichthyosis vulgaris (IV) is a common inherited skin disorder, and the filament aggregating protein (filaggrin) is a key protein involved in skin barrier function. Mutations in the filaggrin gene ( FLG ) have recently been identified as the cause of IV. However, there have been no reports of FLG mutations in mainland Chinese families with IV. Objectives  To identify FLG mutations in Chinese patients with IV. Methods  Eleven unrelated Chinese families with IV were examined for FLG mutations with denaturing high‐performance liquid chromatography prescreening and sequencing. SNaPShot was employed to obtain a high‐throughput screening for the identified mutations. Results  Three mutations – one novel mutation (Q1256X) and two known mutations (3321delA and E2422X) – were identified in these families. The novel mutation, Q1256X, found in a Chinese family with IV, was located in filaggrin repeat 3. Mutation 3321delA, previously found in Japanese patients, was present in eight Chinese families with IV. Mutation E2422X, previously found in a Dutch patient of Chinese origin, was present in two Chinese families with IV. Neither of the null mutations, Q1256X and E2422X, were found in 100 unrelated control cases from the Chinese population; however, the mutation ratio for 3321delA was 3% in these controls. Conclusions  Our study suggests that each population may have a unique and prevalent set of FLG mutations.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here